{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:45:25Z","timestamp":1771508725055,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s11916-022-01024-y","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T06:02:57Z","timestamp":1644559377000},"page":"259-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Devices for Episodic Migraine: Past, Present, and Future"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0366-5994","authenticated-orcid":false,"given":"David","family":"Moreno-Ajona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-9081","authenticated-orcid":false,"given":"Jan","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6577-6825","authenticated-orcid":false,"given":"Simon","family":"Akerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"issue":"11","key":"1024_CR1","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40263-019-00665-9","volume":"33","author":"C Chan","year":"2019","unstructured":"Chan C, Goadsby PJ. Recent advances in pharmacotherapy for episodic migraine. CNS Drugs. 2019;33(11):1053\u201371.","journal-title":"CNS Drugs"},{"issue":"5","key":"1024_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5688\/aj700598","volume":"70","author":"PL Schiff","year":"2006","unstructured":"Schiff PL. Ergot and its alkaloids. Am J Pharm Educ. 2006;70(5):98.","journal-title":"Am J Pharm Educ"},{"issue":"Suppl 4","key":"1024_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/head.12601","volume":"55","author":"C Cameron","year":"2015","unstructured":"Cameron C, Kelly S, Hsieh SC, Murphy M, Chen L, Kotb A, et al. Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache. 2015;55(Suppl 4):221\u201335.","journal-title":"Headache"},{"issue":"7345","key":"1024_CR4","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/S0140-6736(64)91866-5","volume":"1","author":"JW Lance","year":"1964","unstructured":"Lance JW, Curran DA. Treatment of chronic tension headache. Lancet. 1964;1(7345):1236\u20139.","journal-title":"Lancet"},{"key":"1024_CR5","doi-asserted-by":"crossref","unstructured":"Moreno-Ajona D, Villar-Mart\u00ednez MD, Goadsby PJ. Targets for migraine treatment: beyond calcitonin gene-related peptide. Curr Opin Neurol. 2021.","DOI":"10.1097\/WCO.0000000000000935"},{"issue":"1","key":"1024_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","volume":"22","author":"LH Lassen","year":"2002","unstructured":"Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia. 2002;22(1):54\u201361.","journal-title":"Cephalalgia"},{"key":"1024_CR7","doi-asserted-by":"crossref","unstructured":"Goadsby PJ, Edvinsson L. Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90. Headache. 1994;34(7):394\u20139.","DOI":"10.1111\/j.1526-4610.1994.hed3407394.x"},{"issue":"7","key":"1024_CR8","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.cell.2018.11.049","volume":"175","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L. CGRP Antibodies as Prophylaxis in Migraine. Cell. 2018;175(7):1719.","journal-title":"Cell"},{"issue":"3","key":"1024_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/WCO.0000000000000806","volume":"33","author":"D Moreno-Ajona","year":"2020","unstructured":"Moreno-Ajona D, Perez-Rodriguez A, Goadsby PJ. Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment? Curr Opin Neurol. 2020;33(3):309\u201315.","journal-title":"Curr Opin Neurol"},{"issue":"9","key":"1024_CR10","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","volume":"16","author":"S Evers","year":"2009","unstructured":"Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, et al. EFNS guideline on the drug treatment of migraine\u2013revised report of an EFNS task force. Eur J Neurol. 2009;16(9):968\u201381.","journal-title":"Eur J Neurol"},{"issue":"2","key":"1024_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97(2):553\u2013622.","journal-title":"Physiol Rev"},{"issue":"Suppl 2","key":"1024_CR12","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1111\/j.1528-1157.1990.tb05848.x","volume":"31","author":"JK Penry","year":"1990","unstructured":"Penry JK, Dean JC. Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results. Epilepsia. 1990;31(Suppl 2):S40\u20133.","journal-title":"Epilepsia"},{"issue":"1","key":"1024_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1212\/WNL.51.1.48","volume":"51","author":"A Handforth","year":"1998","unstructured":"Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology. 1998;51(1):48\u201355.","journal-title":"Neurology"},{"issue":"6","key":"1024_CR14","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/epi.12611","volume":"55","author":"P Ryvlin","year":"2014","unstructured":"Ryvlin P, Gilliam FG, Nguyen DK, Colicchio G, Iudice A, Tinuper P, et al. The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial. Epilepsia. 2014;55(6):893\u2013900.","journal-title":"Epilepsia"},{"key":"1024_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.yebeh.2014.08.005","volume":"39","author":"L Aihua","year":"2014","unstructured":"Aihua L, Lu S, Liping L, Xiuru W, Hua L, Yuping W. A controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy. Epilepsy Behav. 2014;39:105\u201310.","journal-title":"Epilepsy Behav"},{"issue":"5","key":"1024_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.biopsych.2005.05.025","volume":"58","author":"AJ Rush","year":"2005","unstructured":"Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 2005;58(5):347\u201354.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"1024_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.biopsych.2005.05.024","volume":"58","author":"AJ Rush","year":"2005","unstructured":"Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry. 2005;58(5):355\u201363.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1024_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/head.12647","volume":"56","author":"H Yuan","year":"2016","unstructured":"Yuan H, Silberstein SD. Vagus nerve and vagus nerve stimulation, a comprehensive review: part I. Headache. 2016;56(1):71\u20138.","journal-title":"Headache"},{"issue":"5","key":"1024_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1046\/j.1528-1157.2001.09700.x","volume":"42","author":"SE Krahl","year":"2001","unstructured":"Krahl SE, Senanayake SS, Handforth A. Destruction of peripheral C-fibers does not alter subsequent vagus nerve stimulation-induced seizure suppression in rats. Epilepsia. 2001;42(5):586\u20139.","journal-title":"Epilepsia"},{"key":"1024_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuroscience.2012.07.011","volume":"222","author":"OA Lyubashina","year":"2012","unstructured":"Lyubashina OA, Sokolov AY, Panteleev SS. Vagal afferent modulation of spinal trigeminal neuronal responses to dural electrical stimulation in rats. Neuroscience. 2012;222:29\u201337.","journal-title":"Neuroscience"},{"issue":"Suppl 4","key":"1024_CR21","doi-asserted-by":"publisher","first-page":"S255","DOI":"10.4103\/2152-7806.103015","volume":"3","author":"SE Krahl","year":"2012","unstructured":"Krahl SE, Clark KB. Vagus nerve stimulation for epilepsy: a review of central mechanisms. Surg Neurol Int. 2012;3(Suppl 4):S255\u20139.","journal-title":"Surg Neurol Int"},{"key":"1024_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nbd.2017.03.004","volume":"102","author":"S Akerman","year":"2017","unstructured":"Akerman S, Simon B, Romero-Reyes M. Vagus nerve stimulation suppresses acute noxious activation of trigeminocervical neurons in animal models of primary headache. Neurobiol Dis. 2017;102:96\u2013104.","journal-title":"Neurobiol Dis"},{"key":"1024_CR23","doi-asserted-by":"crossref","unstructured":"Chen SP, Ay I, Lopes de Morais A, Qin T, Zheng Y, Sadeghian H, et al. Vagus nerve stimulation inhibits cortical spreading depression. Pain. 2016;157(4):797\u2013805.","DOI":"10.1097\/j.pain.0000000000000437"},{"issue":"5","key":"1024_CR24","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.pain.2014.02.009","volume":"155","author":"ML Oshinsky","year":"2014","unstructured":"Oshinsky ML, Murphy AL, Hekierski H Jr, Cooper M, Simon BJ. Noninvasive vagus nerve stimulation as treatment for trigeminal allodynia. Pain. 2014;155(5):1037\u201342.","journal-title":"Pain"},{"issue":"7","key":"1024_CR25","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1097\/j.pain.0000000000001856","volume":"161","author":"A Morais","year":"2020","unstructured":"Morais A, Liu TT, Qin T, Sadhegian H, Ay I, Yagmur D, et al. Vagus nerve stimulation inhibits cortical spreading depression exclusively through central mechanisms. Pain. 2020;161(7):1661\u20139.","journal-title":"Pain"},{"issue":"1","key":"1024_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brs.2016.10.008","volume":"10","author":"E Frangos","year":"2017","unstructured":"Frangos E, Komisaruk BR. Access to Vagal Projections via Cutaneous Electrical Stimulation of the Neck: fMRI Evidence in Healthy Humans. Brain Stimul. 2017;10(1):19\u201327.","journal-title":"Brain Stimul"},{"issue":"10","key":"1024_CR27","doi-asserted-by":"publisher","first-page":"e1085","DOI":"10.1212\/WNL.0000000000008865","volume":"94","author":"M Moller","year":"2020","unstructured":"Moller M, Mehnert J, Schroeder CF, May A. Noninvasive vagus nerve stimulation and the trigeminal autonomic reflex: an fMRI study. Neurology. 2020;94(10):e1085\u201393.","journal-title":"Neurology"},{"issue":"2","key":"1024_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1468-2982.2005.00611.x","volume":"25","author":"A Mauskop","year":"2005","unstructured":"Mauskop A. Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia. 2005;25(2):82\u20136.","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"1024_CR29","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1007\/s10072-009-0073-3","volume":"30","author":"AP Cecchini","year":"2009","unstructured":"Cecchini AP, Mea E, Tullo V, Curone M, Franzini A, Broggi G, et al. Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data. Neurol Sci. 2009;30(Suppl 1):S101\u20134.","journal-title":"Neurol Sci"},{"issue":"9","key":"1024_CR30","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jpain.2003.08.001","volume":"4","author":"ED Hord","year":"2003","unstructured":"Hord ED, Evans MS, Mueed S, Adamolekun B, Naritoku DK. The effect of vagus nerve stimulation on migraines. J Pain. 2003;4(9):530\u20134.","journal-title":"J Pain"},{"issue":"6","key":"1024_CR31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1046\/j.1468-2982.2002.00387.x","volume":"22","author":"RM Sadler","year":"2002","unstructured":"Sadler RM, Purdy RA, Rahey S. Vagal nerve stimulation aborts migraine in patient with intractable epilepsy. Cephalalgia. 2002;22(6):482\u20134.","journal-title":"Cephalalgia"},{"issue":"9","key":"1024_CR32","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/ene.12629","volume":"22","author":"E Ben-Menachem","year":"2015","unstructured":"Ben-Menachem E, Revesz D, Simon BJ, Silberstein S. Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability. Eur J Neurol. 2015;22(9):1260\u20138.","journal-title":"Eur J Neurol"},{"issue":"4","key":"1024_CR33","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1212\/WNL.0000000000005857","volume":"91","author":"C Tassorelli","year":"2018","unstructured":"Tassorelli C, Grazzi L, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology. 2018;91(4):e364\u201373.","journal-title":"Neurology"},{"issue":"12","key":"1024_CR34","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1177\/0333102419876920","volume":"39","author":"HC Diener","year":"2019","unstructured":"Diener HC, Goadsby PJ, Ashina M, Al-Karagholi MA, Sinclair A, Mitsikostas D, et al. Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: the multicentre, double-blind, randomised, sham-controlled PREMIUM trial. Cephalalgia. 2019;39(12):1475\u201387.","journal-title":"Cephalalgia"},{"issue":"8","key":"1024_CR35","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/head.12896","volume":"56","author":"SD Silberstein","year":"2016","unstructured":"Silberstein SD, Mechtler LL, Kudrow DB, Calhoun AH, McClure C, Saper JR, et al. Non-invasive vagus nerve stimulation for the acute treatment of cluster headache: findings from the randomized, double-blind, sham-controlled ACT1 Study. Headache. 2016;56(8):1317\u201332.","journal-title":"Headache"},{"issue":"5","key":"1024_CR36","first-page":"e518","volume":"93","author":"CF Schroeder","year":"2019","unstructured":"Schroeder CF, M\u00f6ller M, May A. nVNS sham significantly affects the trigeminal-autonomic reflex. A randomized controlled study. 2019;93(5):e518\u201321.","journal-title":"A randomized controlled study"},{"key":"1024_CR37","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s10194-015-0543-3","volume":"16","author":"A Straube","year":"2015","unstructured":"Straube A, Ellrich J, Eren O, Blum B, Ruscheweyh R. Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial. J Headache Pain. 2015;16:543.","journal-title":"J Headache Pain"},{"key":"1024_CR38","unstructured":"Dressler D, Sch\u00f6nle P, Conrad B. [Transcranial brain stimulation. Methods and results]. Nervenarzt. 1988;59(9):504\u201313."},{"issue":"5","key":"1024_CR39","first-page":"697","volume":"5","author":"PM Rossini","year":"1992","unstructured":"Rossini PM, Caramia MD. Central conduction studies and magnetic stimulation. Curr Opin Neurol Neurosurg. 1992;5(5):697\u2013703.","journal-title":"Curr Opin Neurol Neurosurg"},{"issue":"2","key":"1024_CR40","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.nurt.2010.03.002","volume":"7","author":"RB Lipton","year":"2010","unstructured":"Lipton RB, Pearlman SH. Transcranial magnetic simulation in the treatment of migraine. Neurotherapeutics. 2010;7(2):204\u201312.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"1024_CR41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s10194-017-0792-4","volume":"18","author":"L Lan","year":"2017","unstructured":"Lan L, Zhang X, Li X, Rong X, Peng Y. The efficacy of transcranial magnetic stimulation on migraine: a meta-analysis of randomized controlled trails. J Headache Pain. 2017;18(1):86.","journal-title":"J Headache Pain"},{"key":"1024_CR42","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211.","DOI":"10.1177\/0333102417738202"},{"issue":"2","key":"1024_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1152\/physrev.1959.39.2.239","volume":"39","author":"WH Marshall","year":"1959","unstructured":"Marshall WH. Spreading cortical depression of Leao. Physiol Rev. 1959;39(2):239\u201379.","journal-title":"Physiol Rev"},{"key":"1024_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.brainres.2018.05.046","volume":"1696","author":"GM Tripathi","year":"2018","unstructured":"Tripathi GM, Kalita J, Misra UK. Role of glutamate and its receptors in migraine with reference to amitriptyline and transcranial magnetic stimulation therapy. Brain Res. 2018;1696:31\u20137.","journal-title":"Brain Res"},{"issue":"5","key":"1024_CR45","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/archneur.56.5.548","volume":"56","author":"Y Cao","year":"1999","unstructured":"Cao Y, Welch KM, Aurora S, Vikingstad EM. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol. 1999;56(5):548\u201354.","journal-title":"Arch Neurol"},{"issue":"4","key":"1024_CR46","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s13311-020-00879-6","volume":"17","author":"JO Lloyd","year":"2020","unstructured":"Lloyd JO, Chisholm KI, Oehle B, Jones MG, Okine BN, Al-Kaisy A, et al. Cortical mechanisms of single-pulse transcranial magnetic stimulation in migraine. Neurotherapeutics. 2020;17(4):1973\u201387.","journal-title":"Neurotherapeutics"},{"issue":"3","key":"1024_CR47","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/head.13002","volume":"57","author":"AT Barker","year":"2017","unstructured":"Barker AT, Shields K. Transcranial magnetic stimulation: basic principles and clinical applications in migraine. Headache. 2017;57(3):517\u201324.","journal-title":"Headache"},{"issue":"Pt 7","key":"1024_CR48","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1093\/brain\/aww118","volume":"139","author":"AP Andreou","year":"2016","unstructured":"Andreou AP, Holland PR, Akerman S, Summ O, Fredrick J, Goadsby PJ. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain. 2016;139(Pt 7):2002\u201314.","journal-title":"Brain"},{"issue":"4","key":"1024_CR49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S1474-4422(10)70054-5","volume":"9","author":"RB Lipton","year":"2010","unstructured":"Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010;9(4):373\u201380.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1024_CR50","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10194-006-0329-8","volume":"7","author":"BM Clarke","year":"2006","unstructured":"Clarke BM, Upton AR, Kamath MV, Al-Harbi T, Castellanos CM. Transcranial magnetic stimulation for migraine: clinical effects. J Headache Pain. 2006;7(5):341\u20136.","journal-title":"J Headache Pain"},{"key":"1024_CR51","unstructured":"Mohammad TM, Hughes G, Nkrumah M et al (2006) Self-administered transcranial magnetic stimulation (TMS) during the aura phase improved and aborts headache. Headache 46:857 (abstract)."},{"issue":"6","key":"1024_CR52","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1177\/0333102418762525","volume":"38","author":"AJ Starling","year":"2018","unstructured":"Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hindiyeh N, et al. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study). Cephalalgia. 2018;38(6):1038\u201348.","journal-title":"Cephalalgia"},{"issue":"1","key":"1024_CR53","first-page":"1","volume":"101","author":"PD Wall","year":"1978","unstructured":"Wall PD. The gate control theory of pain mechanisms. A re-examination and re-statement Brain. 1978;101(1):1\u201318.","journal-title":"A re-examination and re-statement Brain"},{"issue":"9","key":"1024_CR54","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1177\/0333102416656118","volume":"37","author":"D Magis","year":"2017","unstructured":"Magis D, D\u2019Ostilio K, Thibaut A, De Pasqua V, Gerard P, Hustinx R, et al. Cerebral metabolism before and after external trigeminal nerve stimulation in episodic migraine. Cephalalgia. 2017;37(9):881\u201391.","journal-title":"Cephalalgia"},{"issue":"8","key":"1024_CR55","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1212\/WNL.0b013e3182825055","volume":"80","author":"J Schoenen","year":"2013","unstructured":"Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gerard P, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80(8):697\u2013704.","journal-title":"Neurology"},{"issue":"1","key":"1024_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0333102418811573","volume":"39","author":"DE Chou","year":"2019","unstructured":"Chou DE, Shnayderman Yugrakh M, Winegarner D, Rowe V, Kuruvilla D, Schoenen J. Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial. Cephalalgia. 2019;39(1):3\u201314.","journal-title":"Cephalalgia"},{"issue":"13","key":"1024_CR57","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1177\/0333102416678623","volume":"37","author":"Y Juan","year":"2017","unstructured":"Juan Y, Shu O, Jinhe L, Na Y, Yushuang D, Weiwei D, et al. Migraine prevention with percutaneous mastoid electrical stimulator: a randomized double-blind controlled trial. Cephalalgia. 2017;37(13):1248\u201356.","journal-title":"Cephalalgia"},{"issue":"6","key":"1024_CR58","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/ner.13127","volume":"23","author":"Y Deng","year":"2020","unstructured":"Deng Y, Zheng M, He L, Yang J, Yu G, Wang J. A head-to-head comparison of percutaneous mastoid electrical stimulator and supraorbital transcutaneous stimulator in the prevention of migraine: a prospective, randomized controlled study. Neuromodulation. 2020;23(6):770\u20137.","journal-title":"Neuromodulation"},{"issue":"4","key":"1024_CR59","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/17434440.2021.1908122","volume":"18","author":"O Daniel","year":"2021","unstructured":"Daniel O, Sharon R, Tepper SJ. A device review of Relivion(R): an external combined occipital and trigeminal neurostimulation (eCOT-NS) system for self-administered treatment of migraine and major depressive disorder. Expert Rev Med Devices. 2021;18(4):333\u201342.","journal-title":"Expert Rev Med Devices"},{"issue":"2","key":"1024_CR60","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/SPC.0000000000000126","volume":"9","author":"RR Nir","year":"2015","unstructured":"Nir RR, Yarnitsky D. Conditioned pain modulation. Curr Opin Support Palliat Care. 2015;9(2):131\u20137.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"8","key":"1024_CR61","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/head.13551","volume":"59","author":"D Yarnitsky","year":"2019","unstructured":"Yarnitsky D, Dodick DW, Grosberg BM, Burstein R, Ironi A, Harris D, et al. Remote electrical neuromodulation (REN) relieves acute migraine: a randomized, double-blind, placebo-controlled, multicenter trial. Headache. 2019;59(8):1240\u201352.","journal-title":"Headache"},{"issue":"13","key":"1024_CR62","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1212\/WNL.0000000000003760","volume":"88","author":"D Yarnitsky","year":"2017","unstructured":"Yarnitsky D, Volokh L, Ironi A, Weller B, Shor M, Shifrin A, et al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology. 2017;88(13):1250\u20135.","journal-title":"Neurology"},{"issue":"12","key":"1024_CR63","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1212\/WNL.0000000000001394","volume":"84","author":"AD Nesbitt","year":"2015","unstructured":"Nesbitt AD, Marin JC, Tompkins E, Ruttledge MH, Goadsby PJ. Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment. Neurology. 2015;84(12):1249\u201353.","journal-title":"Neurology"},{"issue":"1","key":"1024_CR64","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s10194-017-0731-4","volume":"18","author":"C Gaul","year":"2017","unstructured":"Gaul C, Magis D, Liebler E, Straube A. Effects of non-invasive vagus nerve stimulation on attack frequency over time and expanded response rates in patients with chronic cluster headache: a post hoc analysis of the randomised, controlled PREVA study. J Headache Pain. 2017;18(1):22.","journal-title":"J Headache Pain"},{"issue":"10","key":"1024_CR65","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jamaneurol.2017.2122","volume":"74","author":"AR Tso","year":"2017","unstructured":"Tso AR, Marin J, Goadsby PJ. Noninvasive vagus nerve stimulation for treatment of indomethacin-sensitive headaches. JAMA Neurol. 2017;74(10):1266\u20137.","journal-title":"JAMA Neurol"},{"issue":"13","key":"1024_CR66","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1212\/WNL.0000000000010535","volume":"95","author":"D Moreno-Ajona","year":"2020","unstructured":"Moreno-Ajona D, Villar-Mart\u00ednez MD, Goadsby PJ, Hoffmann J. Primary cough headache treated with non-invasive vagal nerve stimulation. Neurology. 2020;95(13):593\u20134.","journal-title":"Neurology"},{"issue":"6","key":"1024_CR67","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/ene.13621","volume":"25","author":"N Karsan","year":"2018","unstructured":"Karsan N, Palethorpe D, Rattanawong W, Marin JC, Bhola R, Goadsby PJ. Flunarizine in migraine-related headache prevention: results from 200 patients treated in the UK. Eur J Neurol. 2018;25(6):811\u20137.","journal-title":"Eur J Neurol"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-022-01024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-022-01024-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-022-01024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T14:40:53Z","timestamp":1666449653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-022-01024-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1024"],"URL":"https:\/\/doi.org\/10.1007\/s11916-022-01024-y","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"assertion":[{"value":"23 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"David Moreno Ajona reports no conflict of interest. Jan Hoffmann received personal fees for consulting, serving on advisory fees and\/or speaking for Allergan, Autonomic Technologies Inc., Cannovex BV, Chordate Medical AB, Eli Lilly, Hormosan Pharma, Lundbeck, Novartis Pharma, Sanofi and Teva. He also received personal fees for Medico-Legal work as well as from Oxford University Press, Quintessence Publishing, Sage Publishing and Springer Healthcare. He receives research support from Bristol Myers Squibb. All these activities are unrelated to the submitted work. Simon Akerman reports personal fees from Amgen, Allergan, and Kallyope, and for Patent\/Legal work in headache and orofacial pain, unrelated to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}